Sign up to save your podcasts
Or
Share The future of radiotheranostics
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The future of radiotheranostics
Ken Herrman (University Hospital Essen, Essen, Germany) discusses a Review in The Lancet Oncology on the role of injectable radiopharmaceuticals with anti-tumour effects.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
View all episodes
By The Lancet Group
5
11 ratings
Ken Herrman (University Hospital Essen, Essen, Germany) discusses a Review in The Lancet Oncology on the role of injectable radiopharmaceuticals with anti-tumour effects.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
More shows like The Lancet Oncology in conversation with
View all
Nature Podcast
758 Listeners
Science Magazine Podcast
808 Listeners
JAMA Editors' Summary
129 Listeners
TED Talks Daily
11,240 Listeners
NEJM Interviews
124 Listeners
6 Minute English
1,763 Listeners
NEJM This Week
315 Listeners
Journal of Clinical Oncology (JCO) Podcast
39 Listeners
Practical Neurology Podcast
34 Listeners
JAMA Clinical Reviews
481 Listeners
ASCO Daily News
54 Listeners
ASCO Guidelines
43 Listeners
The Readout Loud
316 Listeners
The Uromigos
57 Listeners
The Lancet Voice
22 Listeners
The Lancet Child & Adolescent Health in conversation with
0 Listeners
The Lancet Digital Health in conversation with
0 Listeners
The Lancet Global Health in conversation with
2 Listeners
The Lancet Psychiatry in conversation with
1 Listeners
The Lancet Respiratory Medicine in conversation with
1 Listeners
The Lancet in conversation with
0 Listeners
The Lancet Haematology in conversation with
0 Listeners
The Lancet Gastroenterology & Hepatology in conversation with
0 Listeners
The Lancet Diabetes & Endocrinology in conversation with
1 Listeners
The Lancet Infectious Diseases in conversation with
0 Listeners
The Lancet Healthy Longevity in conversation with
0 Listeners
The Lancet Public Health in conversation with
1 Listeners
The Lancet Microbe in conversation with
0 Listeners
In conversation with...
0 Listeners
eBioMedicine in conversation with
0 Listeners
eClinicalMedicine in conversation with
0 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
Two Onc Docs
166 Listeners
The Lancet Regional Health in conversation with
0 Listeners